drugset / Trial / NCT00152295
A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to determine the long-term safety of asoprisnil 10 mg when administered to postmenopausal women with Premarin® 0.625 mg
Timeline
- Start
- 2001-04
- Primary completion
- 2001-12
- Completion
- 2001-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asoprisnil | Other / unclassified | 10 mg | Oral |
| Background | conjugated estrogens | Other / unclassified | 0.625 mg | Oral |
Indications
No indication recorded.